18.07.2013 • NewsBASFDuPontMonsanto

Peltz’ Trian Has Amassed A “Big Stake” in DuPont

Trian Fund Management, headed by Nelson Peltz, has amassed a "big stake" in chemicals maker DuPont, CNBC said on Wednesday.

Shares of DuPont rose 4.8% on the news of Trian's stake. At the CNBC Institutional Investor Delivering Alpha Conference, Peltz declined to comment in response to questions by CNBC host Andrew Ross Sorkin on his DuPont interest.

DuPont declined to a Reuters request for comment. "We don't comment on market rumors or speculation," DuPont spokesman Michael Hanretta said.

Investors have agitated for months about the company's low stock price compared with rivals Monsanto and BASF. While DuPont is the second-largest seed maker after Monsanto, its stock trades at a large discount to its rival.

DuPont's titanium dioxide paint business, the largest in the world, has been blamed by some investors as weighing on the stock. The business is highly cyclical and requires large infusions of cash to maintain during troughs.

 

Free Expert Insights

Dual‑Targeting Breakthroughs
Advancements in Bispecific Antibody Development

Dual‑Targeting Breakthroughs

Unlock the latest breakthroughs in bispecific antibody development! Download Wiley’s free Expert Insights eBook to explore cutting-edge dual-targeting strategies, advanced purification methods, and bioanalytical technologies transforming immunotherapy and cancer treatment.

Virtual Event

Digitalization in the Chemical Industry
CHEManager Spotlight

Digitalization in the Chemical Industry

Save the Date: October 22, 2025
The event will be promoted to a combined audience of over 100,000 professionals across Europe through the CHEManager and CITplus networks.

most read